Correlation Between Verrica Pharmaceuticals and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Virpax Pharmaceuticals.
Diversification Opportunities for Verrica Pharmaceuticals and Virpax Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Verrica and Virpax is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Virpax Pharmaceuticals
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the Virpax Pharmaceuticals. In addition to that, Verrica Pharmaceuticals is 2.2 times more volatile than Virpax Pharmaceuticals. It trades about -0.09 of its total potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.16 per unit of volatility. If you would invest 72.00 in Virpax Pharmaceuticals on August 27, 2024 and sell it today you would lose (15.00) from holding Virpax Pharmaceuticals or give up 20.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Virpax Pharmaceuticals |
Verrica Pharmaceuticals and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Virpax Pharmaceuticals
The main advantage of trading using opposite Verrica Pharmaceuticals and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |